We are live on ! Find out more
CSS

Cubist Systematic Strategies Portfolio holdings

AUM $21B
1-Year Est. Return 21.48%
This Fund
S&P 500
This Quarter Est. Return
-15.79%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.04%
AUM
$16.4B
AUM Growth
+$4.51B
Cap. Flow
+$7.45B
Cap. Flow %
45.53%
Top 10 Hldgs %
3.04%
Holding
4,763
New
1,229
Increased
1,758
Reduced
1,274
Closed
428

Top Buys

Rank Stock Value
1
AXP icon
American Express
AXP
+$71M
2
BAC icon
Bank of America
BAC
+$53.3M
3
MPC icon
Marathon Petroleum
MPC
+$49.5M
4
ILMN icon
Illumina
ILMN
+$47.8M
5
NKE icon
Nike
NKE
+$44.9M

Top Sells

Rank Stock Value
1
VZ icon
Verizon
VZ
+$43.1M
2
ZTS icon
Zoetis
ZTS
+$33.2M
3
CL icon
Colgate-Palmolive
CL
+$25.5M
4
QCOM icon
Qualcomm
QCOM
+$23.7M
5
FRC
First Republic Bank
FRC
+$23.1M

Sector Composition

Rank Sector Weight
1 Financials 15.38%
2 Technology 14.53%
3 Consumer Discretionary 10.24%
4 Healthcare 9.93%
5 Industrials 9.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WINV
3726
DELISTED
WinVest Acquisition Corp. Common Stock
WINV
$192K ﹤0.01%
19,272
+7,183
+59% +$71.4K
CD
3727
DELISTED
Chindata Group Holdings Limited American Depositary Shares
CD
$192K ﹤0.01%
24,791
-45,561
-65% -$294K
AKRO
3728
DELISTED
Akero Therapeutics
AKRO
$191K ﹤0.01%
20,243
+12,277
+154% +$128K
CVM icon
3729
CEL-SCI Corp
CVM
$30.1M
$191K ﹤0.01%
1,414
-2,913
-67% -$303K
RXRX icon
3730
Recursion Pharmaceuticals
RXRX
$1.73B
$191K ﹤0.01%
23,408
-65,340
-74% -$437K
WHWK
3731
Whitehawk Therapeutics
WHWK
$271M
$191K ﹤0.01%
15,538
+2,712
+21% +$40.3K
CRU.U
3732
DELISTED
Crucible Acquisition Corporation Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant
CRU.U
$191K ﹤0.01%
+19,377
New +$191K
LENZ
3733
LENZ Therapeutics
LENZ
$168M
$190K ﹤0.01%
9,856
+7,539
+325% +$168K
PORT.U
3734
DELISTED
Southport Acquisition Corporation Units, each consisting of one share of Class A common stock, and one-half of one warrant
PORT.U
$190K ﹤0.01%
+18,400
New +$185K
AVIR icon
3735
Atea Pharmaceuticals
AVIR
$420M
$189K ﹤0.01%
26,656
-97,884
-79% -$668K
CSTE icon
3736
Caesarstone
CSTE
$79.5M
$189K ﹤0.01%
+20,688
New +$198K
SND icon
3737
Smart Sand
SND
$194M
$189K ﹤0.01%
94,554
+43,575
+85% +$151K
GFX
3738
DELISTED
Golden Falcon Acquisition Corp.
GFX
$189K ﹤0.01%
+19,175
New +$189K
TBSAU
3739
DELISTED
TB SA Acquisition Corp Unit
TBSAU
$188K ﹤0.01%
19,188
-8,711
-31% -$85.8K
JYAC
3740
DELISTED
Jiya Acquisition Corp. Class A Common Stock
JYAC
$188K ﹤0.01%
+19,026
New +$188K
WSFS icon
3741
WSFS Financial
WSFS
$4.15B
$187K ﹤0.01%
+4,665
New +$192K
SDACU
3742
DELISTED
Sustainable Development Acquisition I Corp. Unit
SDACU
$186K ﹤0.01%
+18,961
New +$187K
CECO icon
3743
Ceco Environmental
CECO
$4.14B
$185K ﹤0.01%
+30,948
New +$172K
TEAD
3744
Teads Holding Co
TEAD
$67.7M
$185K ﹤0.01%
36,752
+251
+0.7% +$1.89K
LHC.U
3745
DELISTED
Leo Holdings Corp. II Units, each consisting of one Class A ordinary share and one-quarter of one redeemable warrant
LHC.U
$184K ﹤0.01%
+18,748
New +$185K
NLSN
3746
DELISTED
Nielsen Holdings plc
NLSN
$184K ﹤0.01%
+7,943
New +$203K
O icon
3747
Realty Income
O
$59.1B
$183K ﹤0.01%
2,681
-48,763
-95% -$3.35M
PLCE icon
3748
Children's Place
PLCE
$59.8M
$183K ﹤0.01%
4,693
-88,969
-95% -$4.18M
SANA icon
3749
Sana Biotechnology
SANA
$980M
$183K ﹤0.01%
28,493
-25,483
-47% -$162K
SLACU
3750
DELISTED
Social Leverage Acquisition Corp I Units, each consisting of one share of Class A common stock and one-fourth of one redeemable warrant
SLACU
$183K ﹤0.01%
+18,637
New +$184K
148 149
150
151 152

Similar funds

GIM
Glenmede Investment Management Philadelphia, Pennsylvania $20.7B AUM
ECM
Eisler Capital Management London, United Kingdom $22.6B AUM 9.36% 1-Year Est. Return
JFL
Jarislowsky, Fraser Ltd Montreal, Quebec, Canada $18.2B AUM 22.04% 1-Year Est. Return
BAM
Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return
SF
Synovus Financial Columbus, Georgia $8.74B AUM 12.78% 1-Year Est. Return
WIM
Waverton Investment Management London, United Kingdom $7.77B AUM 25.07% 1-Year Est. Return
AIM
AXA Investment Managers Puteaux, France $37.1B AUM
SIG
Stonegate Investment Group Birmingham, Alabama $4.31B AUM 18.07% 1-Year Est. Return

Cubist Systematic Strategies's Q2 2022 Portfolio in Review

As of Q2 2022, Cubist Systematic Strategies held 4,763 positions worth $16.4B, up 38% from $11.8B the previous quarter. Its ten largest holdings account for 3% of the portfolio.

Cubist Systematic Strategies deployed $7.45B of net new capital in Q2 2022, opening 1,229 new positions and adding to 1,758 existing holdings. Its largest new stake was Sierra Lake Acquisition Corp. Class A Common Stock: 1,393,075 shares worth $13.8M.

By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 18% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Verizon, an estimated $43.1M trimmed.

  • Cubist Systematic Strategies's largest Q2 2022 buy was Sierra Lake Acquisition Corp. Class A Common Stock: 1,393,075 shares worth $13.8M.
  • Cubist Systematic Strategies added most to American Express in Q2 2022, an estimated $71M increase.
  • Cubist Systematic Strategies's biggest Q2 2022 reduction was Verizon, cutting an estimated $43.1M.
  • Cubist Systematic Strategies fully exited UnitedHealth in Q2 2022, selling an estimated $17.1M.
  • Cubist Systematic Strategies's ten largest holdings make up 3% of its $16.4B portfolio in Q2 2022.
  • Cubist Systematic Strategies opened 1,229 new positions and closed 428 in Q2 2022.
  • Cubist Systematic Strategies's portfolio value rose 38% quarter-over-quarter to $16.4B.

Based on Cubist Systematic Strategies's 13F filing for Q2 2022, filed 15 Aug 2022.